Shell Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-5,901
| Closed | -$366K | – | 1475 |
|
|
2020
Q4 | $366K | Hold |
5,901
| – | – | 0.01% | 926 |
|
|
2020
Q3 | $351K | Hold |
5,901
| – | – | 0.01% | 843 |
|
|
2020
Q2 | $412K | Buy |
5,901
+747
| +14% | +$52.2K | 0.01% | 748 |
|
|
2020
Q1 | $234K | Sell |
5,154
-80
| -2% | -$3.63K | 0.01% | 962 |
|
|
2019
Q4 | $341K | Sell |
5,234
-197
| -4% | -$12.8K | 0.01% | 1015 |
|
|
2019
Q3 | $337K | Sell |
5,431
-46
| -0.8% | -$2.85K | 0.01% | 1039 |
|
|
2019
Q2 | $390K | Sell |
5,477
-125
| -2% | -$8.9K | 0.01% | 1004 |
|
|
2019
Q1 | $439K | Hold |
5,602
| – | – | 0.01% | 965 |
|
|
2018
Q4 | $474K | Sell |
5,602
-481
| -8% | -$40.7K | 0.01% | 860 |
|
|
2018
Q3 | $1.04M | Buy |
+6,083
| New | +$1.04M | 0.02% | 639 |
|
|
2016
Q4 | – | Sell |
-7,906
| Closed | -$503K | – | 1084 |
|
|
2016
Q3 | $503K | Buy |
+7,906
| New | +$503K | 0.01% | 864 |
|